DKA treatment is an emergency hospital protocol built around three parallel interventions: intravenous fluid resuscitation, a continuous insulin infusion, and careful potassium replacement. Care takes place in an emergency department, ICU, or step-down unit. Most cases resolve in 12 to 24 hours, but patients typically stay 2 to 3 days for stabilization.
What Is Diabetic Ketoacidosis
Diabetic ketoacidosis (DKA) occurs when the body lacks enough insulin to move glucose into cells. The liver then breaks down fat for fuel, producing ketones. Ketones accumulate in the blood, lowering pH and triggering dehydration, electrolyte shifts, and organ stress. Classic diagnostic criteria are:
- Blood glucose over 250 mg/dL (can be lower in euglycemic DKA with SGLT2 inhibitors)
- Arterial or venous pH below 7.30
- Serum bicarbonate below 18 mEq/L
- Positive serum or urine ketones
- Elevated anion gap above 12
For background on the chemistry involved, see our guides on ketones in urine and urine ketone testing.
Initial Emergency Department Assessment
When a patient arrives with suspected DKA, the clinical team simultaneously:
- Places two large-bore IV lines
- Draws labs: glucose, basic metabolic panel, venous blood gas, ketones (beta-hydroxybutyrate preferred), complete blood count, phosphorus, magnesium
- Places the patient on cardiac monitoring
- Performs a focused history and exam to identify the DKA trigger
- Gets an EKG, chest X-ray, and urinalysis
- Starts IV normal saline immediately, before labs return
Phase 1: IV Fluid Resuscitation
Patients in DKA are typically 6 to 10 liters dehydrated. Fluid replacement begins immediately and continues throughout treatment.
First Hour
Normal saline (0.9% NaCl) is infused at 15 to 20 mL/kg/hour, usually 1 to 1.5 liters. This restores circulating volume and begins to lower glucose by dilution alone.
Hours 2 to 24
Fluid type switches based on corrected sodium. If sodium is normal or high, switch to 0.45% saline at 250 to 500 mL/hour. If sodium is low, continue normal saline.
Once blood glucose falls to 200 to 250 mg/dL, 5% dextrose is added to the IV fluids to prevent hypoglycemia while the insulin drip continues clearing ketones.
Phase 2: Insulin Infusion
IV regular insulin is the cornerstone of DKA treatment. Most protocols follow this sequence:
- Bolus (optional): 0.1 units/kg IV push
- Continuous infusion: 0.1 units/kg/hour, titrated to drop glucose 50 to 75 mg/dL per hour
- Adjustment: Increase rate if glucose is not falling; decrease or add dextrose once glucose is under 250 mg/dL
Insulin is continued intravenously until the anion gap closes – this is the signal that ketoacidosis has resolved, not simply a normal glucose level.
Phase 3: Potassium and Electrolyte Replacement
DKA causes a deceptive potassium picture. Total body potassium is depleted, but serum levels may read normal or high initially because acidosis pulls potassium out of cells. Insulin treatment then drives potassium back into cells and can cause dangerous hypokalemia.
| Serum Potassium (mEq/L) | Action |
|---|---|
| Below 3.3 | Hold insulin; give 20 to 30 mEq KCl per hour until potassium above 3.3 |
| 3.3 to 5.2 | Add 20 to 30 mEq KCl per liter of IV fluid |
| Above 5.2 | Do not supplement; recheck in 2 hours |
Phosphorus and magnesium are also often depleted and replaced if significantly low.
Monitoring Protocol
DKA care is labor-intensive. According to the ADA consensus statement, recommended monitoring includes:
- Fingerstick glucose every 1 hour
- Basic metabolic panel (electrolytes, glucose, bicarbonate, anion gap) every 2 to 4 hours
- Venous blood gas every 2 to 4 hours until pH above 7.3
- Continuous cardiac monitoring
- Strict intake and output
- Neurologic checks – any change in mental status can signal cerebral edema, especially in children
DKA Treatment Timeline
| Time From Presentation | Typical Milestone |
|---|---|
| 0 – 1 hour | IV access, labs drawn, first liter of normal saline, insulin drip started |
| 2 – 4 hours | Glucose falling 50 – 75 mg/dL/hr, electrolytes replaced, fluid type adjusted |
| 6 – 12 hours | Glucose reaches 200 mg/dL, dextrose added, anion gap narrowing |
| 12 – 24 hours | Anion gap closes, ketoacidosis resolves, patient allowed to eat |
| Transition | Subcutaneous long-acting insulin given 1 – 2 hours before IV drip is stopped |
| Day 2 – 3 | Discharge planning, diabetes education, trigger management |
Transitioning From IV to Subcutaneous Insulin
The switch is the most common place for errors. Key rules:
- Only transition when the anion gap has closed and the patient can eat
- Give a long-acting subcutaneous insulin dose (glargine or detemir) 1 to 2 hours before stopping the drip
- Overlap prevents rebound ketosis
- Typical total daily dose is 0.5 to 0.8 units/kg split between basal and bolus insulin
Complications of DKA Treatment
- Hypoglycemia – prevented by adding dextrose when glucose falls under 250 mg/dL
- Hypokalemia – prevented by aggressive potassium replacement
- Cerebral edema – rare but most common in children; signs are headache, vomiting, and falling alertness
- Volume overload – more likely in elderly or heart failure patients
- Acute kidney injury – usually improves with volume resuscitation
Identifying the Trigger
Before discharge, the team identifies and treats the cause:
- Infection screen (blood and urine cultures, chest X-ray)
- EKG and troponin for heart attack
- Review of insulin adherence, pump function, sick-day rules
- Pregnancy test in women of childbearing age
- Toxicology for suspected substance use
According to the NIDDK, up to 20 percent of DKA episodes are first presentations of previously undiagnosed type 1 diabetes.
Prevention After Discharge
- Sick-day plan: check glucose and ketones every 4 hours during illness
- Never skip insulin, even when not eating
- Continuous glucose monitor or ketone meter for high-risk patients
- Rapid call to doctor if glucose exceeds 250 mg/dL twice and ketones are positive
- Diabetes education referral
The Bottom Line
DKA treatment is a hospital-based protocol of IV fluids, insulin infusion, and potassium replacement, with tight monitoring every 1 to 4 hours. Most patients resolve within 24 hours but remain hospitalized for education and trigger treatment. For related medication topics, see our diabetes medications overview.
